Catheter Market | USD 110.17 Billion by 2034

The catheter market size was exhibited at USD 58.25 billion in 2024 and is projected to hit around USD 110.17 billion by 2034, growing at a CAGR of 6.58% during the forecast period 2024 to 2034.

Catheter Market Key Takeaways:

• Cardiovascular catheter segment led the market and accounted for 27.99% of the total revenue share in 2024.
• Hospital stores segment dominated the market with the largest revenue share in 2024.
• The retail stores segment is projected to witness the highest growth rate over the forecast period.
• North America accounted for 31.72% of the global market in 2024 and is expected to continue its dominance over the forecast period.
• Indian market is anticipated to grow at a CAGR of 7.7% over the forecast period.

?????????????? ?????? ???????? ???????????? ????????????: https://www.novaoneadvisor.com/report/sample/1059

The increasing cases of chronic disorders such as neurological, cardiovascular, and urological disorders requiring hospitalization boosts the expansion of the market. For instance, as per the reports published by the National Library of Medicine in 2023, approximately around 15% of the global population suffer from neurological disorders, which causes physical and cognitive disabilities.

According to the WHO, over 200 million individuals worldwide are affected by various urological disorders. In the U.S., urological disorders impact nearly 25 million people, with women constituting 80% of this population. With the increasing prevalence of conditions such as urinary retention, UI, benign prostatic hyperplasia, and neurogenic bladder dysfunction, there has been a growing demand for catheterization for short-term or long-term management of these ailments. Furthermore, the market is anticipated to experience growth in the forecast period due to a surge in midscale catheter manufacturers competing for a larger market share.

Major market players use advanced materials, such as polyurethanes/polycarbonates, to manufacture catheters. Carbothane, resistant to chemicals such as iodine, hydrogen peroxide, or alcohol is used to make catheters to increase their longevity. For instance, MAHURKAR Chronic Carbothane catheter, manufactured by Medtronic, is easy to insert with a single technique and ensuring top-notch resistance to kinks. This catheter provides impressive flow rates with minimal pressure on both arterial and venous systems.

Moreover, catheters made of Durathane offer resistance and strength. For example, the DuraFlow 2 chronic hemodialysis catheter, offered by AngioDynamics, is made of Durathane, which offers advantages of both silicone and polyurethane. This catheter material offers strength and is resistant to a variety of commonly used site care agents. Thus, the use of advanced materials to manufacture catheters is increasing their demand among end users.

The increasing awareness of controlling catheter-related bloodstream infections (CRBSI) among the people will contribute to a greater demand for catheters in the coming forecast period. A significant factor leading to catheter-related bloodstream infections (CRBSI) is the lack of proper care and maintenance for these devices. Healthcare professionals are preferring the use of catheters that pose minimal infection risks due to their increased awareness and emphasis on infection control. For instance, in May 2023, BD introduced a convenient prefilled flush syringe for customers. This innovative BD PosiFlush SafeScrub syringe is designed to enhance patient care by expediting the flushing and disinfection of IV catheters during clinical procedures. Ensuring the cleanliness and disinfection of catheters is crucial in preventing CRBSIs. As a result, healthcare professionals are becoming more aware of the significance outlined in infection prevention guidelines, enhancing the need for the proper flushing, and disinfecting of catheters.

Moreover, treatment of Peripheral Artery Disease (PAD) is usually followed by a minimally invasive procedure that involves the use of catheters to clear the blocked arteries. Growing preference for angioplasty over conventional surgeries has resulted in a rise in the demand for this procedure among patients. As peripheral angioplasty is a minimally invasive procedure and offers better outcomes, it has gained significant popularity over the past decade. The growing demand for minimally invasive procedures can also be attributed to the recent technological innovations, for instance, use of antimicrobial coating and miniaturized catheters to prevent the risk of restenosis. These procedures have higher adoption rates and are becoming standard techniques in general surgery due to the use of advanced technologies and innovative coated catheters available in the market. Thus, the growing preference for minimally invasive surgeries is expected to drive the growth of the catheters market during the forecast period.

Catheter Market By Product Type Insights

Cardiovascular catheter segment led the market and accounted for 27.99% of the total revenue share in 2024. Rising prevalence of cardiovascular disorders and increasing demand for interventional cardiac procedures, coupled with growing adoption of cardiac catheters, are expected to boost the growth of the market for cardiovascular catheters during the forecast period. For instance, according to data released by the American College of Cardiology in July 2023, around 200 million individuals globally, and over 12 million people in the U.S., are dealing with peripheral artery disease (PAD). The increasing demand for these catheters can be attributed to the increasing incidence of cardiac conditions such as coronary artery disease, congenital heart problems, and cardiac arrhythmia. As the occurrence of these conditions rises, there is an increased need for diagnostic and interventional procedures, with cardiovascular catheters playing a pivotal role in performing minimal invasive procedures.

Catheter Market By End-Use Insights

Hospital stores segment dominated the market with the largest revenue share in 2024. Hospital stores are situated in the hospital premises where it stores and dispenses a wide range of catheters required for the surgical and minimal invasive procedures. Unlike regular pharmacies catering to outpatients, hospital stores prioritize the needs of patients admitted to the hospital. These cater to specific and often rare medical conditions, requiring precise storage and handling protocols.

Moreover, due to the critical nature of their function, hospital stores operate under strict regulations. These regulations govern everything from storage conditions and dispensing procedures to personnel qualifications and record-keeping practices. This stringent framework ensures patient safety and medication accuracy. Additionally, modern hospital stores leverage cutting-edge technology to streamline operations and optimize medication management. Automated dispensing systems, electronic prescribing platforms, and advanced inventory tracking software are just a few examples. These technologies minimize errors, improve efficiency, and enhance patient care. Time is often of the essence in healthcare, and hospital stores ensure immediate access to the needed catheters. This reduces delays in treatment and potentially improves patient outcomes. These factors boost the demand for catheters in the hospital stores, driving the market growth.

The retail stores segment is projected to witness the highest growth rate over the forecast period. This is attributed to the availability of various e-commerce platforms which sell catheters. These platforms offer convenient, choice-filled, and often cost-effective way to purchase the catheters. For instance, the e-commerce sites that offer warranty, discounts, and prompt customer service for catheters are Shopcatheters, Allegro Medical Supplies Inc., and Amazon. This has a positive impact on the sales of the products through these sales channels. Thus, supporting the segment growth during the forecast period.

Catheter Market By Regional Insights

North America accounted for 31.72% of the global market in 2024 and is expected to continue its dominance over the forecast period. This can be ascribed to various factors, including the growing incidence of chronic illnesses and an aging population, as well as the favorable impact of major manufacturers like Teleflex Incorporated, Medtronic, and Boston Scientific Corporation enhancing regional growth. The market for catheters in North America has expanded due to favorable government regulations, rising public awareness, a large number of highly competent health care providers, and the presence of prominent healthcare facilities.

The demand for catheters may be positively impacted by greater patient and healthcare community understanding of the importance of early identification and treatment for chronic illnesses. The Centers for Medicare & Medicaid Services (CMS), for instance, predicted that in 2022, health spending in the U.S. will be 7.5% of GDP. It was predicted to cross $1 trillion in 2023. In addition, high disposable income in developed economies & skilled professionals are some factors responsible for the large share of the market of the country.

Asia Pacific region is anticipated to grow at the fastest CAGR over the forecast period. This can be attributed to the presence of large population suffering from kidney & cardiovascular diseases, improvement in medical facilities, and availability of insurance policies. Increased surgical volume, growing government partnerships, and a developing medical device portfolio all contribute to regional growth. Additionally, an increase in government initiatives contributes to market developments in the region.

For instance, in July 2022, the Asia Pacific Society of Infection Control introduced the APSIC guide on the prevention of catheter-linked UI infections. The program focuses on offering practical recommendations provided in a brief format to help healthcare facilities in Asia Pacific maintain high standards of infection prevention & management. Its primary objective was to guide the management and care of patients with a urinary catheter. Moreover, the presence of a large patient pool and the growing need for technologically advanced & cost-efficient healthcare solutions are expected to present significant regional growth opportunities in the market.

Indian market is anticipated to grow at a CAGR of 7.7% over the forecast period. The key factors estimated to drive the Indian market are adoption of new technology in catheter manufacturing, growing disease variation and prevalence, and increasing research and development for enhancing the product portfolio.

Catheter Market Recent Developments

• In October 2024, B. Braun introduced the Introcan Safety 2 IV Catheter, featuring multi-access blood control, designed to ensure the protection of clinicians each time the hub is accessed
• In October 2024, the Orchid SRV safety released valves was approved by the U.S. FDA, according to Linear Health Sciences. The purpose of the catheter, which had been authorized to be employed with all IV access procedures, was to reduce the likelihood of IV catheter rupture and repair in hospitals
• In February 2024, Teleflex Incorporated declared that the U.S. FDA had granted its Triumph Catheter's 510(k) clearance. This innovative device features clear visualization and exact wire progression. Furthermore, the business reported that the UW Medicine Heart Institute in Seattle, Washington, witnessed the first clinical use of its GuideLiner Coast Catheter
• In December 2023, Boston Scientific declared the goal to acquire a controlling position in Acotec Scientific Holdings Limited, a Chinese medical technology business, through a strategic investment. In addition to thrombus aspiration catheters and radiofrequency ablation technologies, the company is highly renowned in China for its drug-coated balloons (DCBs). With this transaction, Boston Scientific intended to improve its position in this region
• In February 2023, Medtronic declared that the FDA had approved the use of its Freezor Xtra Cardiac Cryoablation and Freezor and Focal Catheters for the treatment of juvenile Atrioventricular Nodal Reentrant Tachycardia (AVNRT). The catheters are single-use, flexible devices that help treat the problem by freezing cardiac tissue and obstructing any unwanted electrical signals within the heart

Some of the prominent players in the catheter market include:

• Hollister Incorporated
• Medtronic
• Boston Scientific Corporation
• Edward Lifesciences
• Smith Medical Inc.
• Teleflex Incorporated
• ConvaTec Group Plc
• Cure Medical LLC

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the catheter market

Product Type

• Cardiovascular Catheters

• Electrophysiology Catheters
• PTCA Balloon Catheters
• IVUS Catheters
• PTA Balloon Catheters

• Urology Catheters

• Hemodialysis Catheters
• Peritoneal Catheters
• Foley Catheters
• Intermittent Catheters
• External Catheters

• Intravenous Catheters

• Peripheral Catheters
• Midline Peripheral Catheters
• Central Venous Catheters

• Neurovascular Catheters
• Specialty Catheters

• Wound/Surgical Catheters
• Oximetry Catheters
• Thermodilution Catheters
• IUI Catheters

End Use

• Hospital Stores
• Retail Stores
• Others

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Immediate Delivery Available | Buy This Premium Research https://www.novaoneadvisor.com/report/checkout/1059

Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com

You can place an order or ask any questions, please feel free to [email protected]| +1 9197 992 333

About US

Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Connect with Us

Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

IND Address: 707, Nandan Probiz, Baner,?Pune (MH) – 411045, India

USA:?+1 804 441 9344

APAC:?+61 485 981 310 or +91 87933 22019

Europe:?+44 7383 092 044

Email: [email protected]

Web: https://www.novaoneadvisor.com/

You can place an order or ask any questions, please feel free to contact at?[email protected] ?| +1 804 441 9344

Nova One Advisor Group Offer Other Reports:

Cell Therapy Market Size and Forecast:?The global?cell therapy market size was exhibited at USD 4.85 billion in 2023 and is projected to hit around USD 37.42 billion by 2033, growing at a CAGR of 22.67% during the forecast period 2024 to 2033.

Gene Therapy Market Size and Forecast?:?The global?gene therapy market size was exhibited at USD 8.75 billion in 2023 and is projected to hit around USD 52.40 billion by 2033, growing at a CAGR of 19.6% during the forecast period 2024 to 2033.

Cell And Gene Therapy Manufacturing Market Size and Forecast:?The global?cell and gene therapy manufacturing market size was estimated at USD 9.95 billion in 2023 and is projected to hit around USD 106.03 billion by 2033, growing at a CAGR of 26.7% during the forecast period from 2024 to 2033.

Cell and Gene Therapy Market?Size and Forecast:?The global?cell and gene therapy market size was estimated at USD 18.13 billion in 2023 and is projected to hit around USD 97.33 billion by 2033, growing at a CAGR of 18.3% during the forecast period from 2024 to 2033.

U.S. Cell Therapy Market Size and Forecast:?The?U.S. cell therapy market size was estimated at USD 2.88 billion in 2023 and is projected to hit around USD 19.67 billion by 2033, growing at a CAGR of 21.18% during the forecast period from 2024 to 2033.

U.S. Gene Therapy Market Size and Forecast:?The?U.S. gene therapy market size?was estimated at USD 3.19 billion in 2023 and is projected to hit around USD 18.50 billion by 2033, growing at a CAGR of 19.22% during the forecast period from 2024 to 2033.

T-cell Therapy Market Size and Forecast:?The global?T-Cell therapy market size?was exhibited at USD 3.85 billion in 2023 and is projected to hit around USD 79.62 billion by 2033, growing at a CAGR of 35.38% during the forecast period 2024 to 2033.

Cancer Immunotherapy Market?Size and Forecast:?The global?cancer immunotherapy market?size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.

Immunotherapy Drugs Market?:?The global?immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.

Clinical Trials Market Size and Forecast:?The?global clinical trials market size was estimated at USD 81.90 billion in 2023 and is projected to hit around USD 153.59 billion by 2033, growing at a CAGR of 6.49% during the forecast period from 2024 to 2033.

Biologics Market Size and Forecast: The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.

Biotechnology Market Size and Forecast:? The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.

Oncology? Market Size and Forecast: The?global oncology market size was estimated at USD 222.36 billion in 2023 and is projected to hit around USD 521.60 billion by 2033, growing at a CAGR of 8.9% during the forecast period from 2024 to 2033.

Cell And Gene Therapy Clinical Trials?Market Size and Forecast: The global cell and gene therapy clinical trials market size reached USD 11.62 billion in 2023 and is projected to hit around USD 47.40 billion by 2033, expanding at a CAGR of 15.09% during the forecast period from 2024 to 2033.

U.S. Clinical Trials Market Size and Forecast:?The?U.S. clinical trials market size was valued at USD 25.81 billion in 2023 and is projected to surpass around USD 41.57 billion by 2033, registering a CAGR of 4.88% over the forecast period of 2024 to 2033.

Active Pharmaceutical Ingredient CDMO Market:?The global active pharmaceutical ingredient CDMO market size was valued at USD 119.80 billion in 2023 and is anticipated to reach around USD 249.22 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.

U.S. Pharmaceutical Market?:?The U.S. pharmaceutical market size was valued at USD 602.19 billion in 2023 and is projected to surpass around USD 1,093.79 billion by 2033, registering a CAGR of 6.15% over the forecast period of 2024 to 2033.

Viral Vector And Plasmid DNA Manufacturing Market:?The global viral vector and plasmid DNA manufacturing market size?was valued at USD 6.19 billion in 2023 and is anticipated to reach around USD 39.30 billion by 2033, growing at a CAGR of 20.3% from 2024 to 2033.

U.S. Viral Vector And Plasmid DNA Manufacturing Market ;?The U.S. viral vector and plasmid DNA manufacturing market size was valued at USD 2.45 billion in 2023 and is expected to be worth around USD 15.30 billion by 2033, with a registered CAGR of 20.1% during forecast period 2024 to 2033.

Compounding Pharmacies Market :?The global compounding pharmacies market size?was valued at USD 16.19 billion in 2023 and is anticipated to reach around USD 30.97 billion by 2033, growing at a CAGR of 6.7% from 2024 to 2033.

U.S. Compounding Pharmacies Market?:?The U.S. compounding pharmacies market size?is projected to be worth around USD 10.76 billion by 2033 from USD 6.31 billion in 2024, at a CAGR of 6.1% from 2024 to 2033.

Antibiotics Market: The?global antibiotics market size?was valued at USD 51.19 billion in 2023 and is projected to surpass around USD 85.80 billion by 2033, registering a CAGR of 5.3% over the forecast period of 2024 to 2033.

Biologics Market :?The?global biologics market size was estimated at USD 511.04 billion in 2023 and is projected to hit around USD 1,374.51 billion by 2033, growing at a CAGR of 10.4% during the forecast period from 2024 to 2033.

Biotechnology Market:?The?global biotechnology market size was estimated at USD 1.54 Trillion in 2023 and is projected to hit around USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% during the forecast period from 2024 to 2033.

Next Generation Sequencing Market?:?The?global next generation sequencing market size was estimated at USD 9.19 billion in 2023 and is projected to hit around USD 66.04 billion by 2033, growing at a CAGR of 21.8% during the forecast period from 2024 to 2033.

Genome Editing Market ;?The?global genome editing market size?was valued at USD 8.45 billion in 2023 and is anticipated to reach around USD 40.48 billion by 2033, growing at a CAGR of 16.96% from 2024 to 2033.

U.S. Genome Editing Market:?The?U.S. genome editing market size was estimated at USD 3.55 billion in 2023 and is projected to hit around USD 16.49 billion by 2033, growing at a CAGR of 16.6% during the forecast period from 2024 to 2033.

U.S. Gene Synthesis Market?:?The?U.S. Gene Synthesis market size was valued at USD 700.90 million in 2023 and is projected to surpass around USD 3,118.73 million by 2033, registering a CAGR of 16.1% over the forecast period of 2024 to 2033.

Biopharmaceutical Market :?The global?Biopharmaceutical market size accounted for USD 327.46 billion in 2022 and is estimated to achieve a market size of USD 1,101.77 billion by 2032 growing at a CAGR of 12.9% from 2023 to 2032.

Immunotherapy Drugs Market?:?The?global immunotherapy drugs market size was valued at USD 240.19 billion in 2023 and is projected to surpass around USD 1,300.38 billion by 2033, registering a CAGR of 18.4% over the forecast period of 2024 to 2033.

Cancer Immunotherapy Market:?The global cancer immunotherapy market size was valued at USD 126.19 billion in 2023 and is projected to surpass around USD 296.01 billion by 2033, registering a CAGR of 8.9% over the forecast period of 2024 to 2033.

U.S. Plasmid DNA Manufacturing Market?:?The U.S. plasmid DNA manufacturing market size?was valued at USD 711.90 million in 2023 and is projected to surpass around USD 4,885.15 million by 2033, registering a CAGR of 21.24% over the forecast period of 2024 to 2033.

U.S. Precision Medicine Market?:?The?U.S. precision medicine market size was valued at USD 24.95 billion in 2023 and is projected to reach around USD 76.12 billion by 2033, registering a CAGR of 11.80% from 2024 to 2033.